CytoSorbents Corporation (CTSO)

[ping_pow_princess]

I initially thought about cash raising because of where the share price is right now. Near the 52 week high. In last Q2, they stated that with the current cash and revenue projection, they have enough cash to the end of next year. This is for operating expenses only. They would need more for clinical trials. The other big expenditure expected is the upgrade of their manufacturing which is expected to come online early 2018 but I think they would have taken this into account. Revenue will continue to grow as more countries start contributing. In looking at the inventory at the close of Q2, I don’t expect a big jump in revenue. I think new customers are being asked to register in the CytoSorb registry and start off as test users until they are comfortable using it and doing the knowledge transfer to other staff. Perhaps the CytoSorb devices are put in under Research or Sales Expenses for this.